Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26ᵗʰ
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Indivior (Nasdaq: INDV) will report its fourth quarter and full-year 2025 financial results on Thursday, February 26, 2026 at 7:00 a.m. U.S. EST, followed by a live webcast presentation at 8:00 a.m. U.S. EST led by CEO Joe Ciaffoni and the leadership team.
Webcast access, registration details, and a replay will be available in the Investors section of the company website.
Details
News Market Reaction – INDV
On Jan 28, the day this news came out, INDV closed 0.55% above the previous close.
Data tracked by StockTitan Argus for the Jan 28 session.
Key Figures
- Earnings release time
- 7:00 a.m. U.S. EST
- Fourth quarter and full-year 2025 results on Feb 26, 2026
- Webcast time
- 8:00 a.m. U.S. EST
- Management presentation on Feb 26, 2026 following earnings release
Historical Context
-
Completion of move to U.S. domicile with new Delaware parent structure.
-
Issued detailed 2026 revenue, SUBLOCADE, OPEX and EBITDA guidance.
-
Added to S&P SmallCap 600 index, reinforcing U.S. small-cap profile.
-
SUBLOCADE study showed rapid and sustained reductions in opioid use.
-
Paid $295M from cash on hand to terminate DOJ resolution agreement.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
RICHMOND, Va., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its fourth quarter and full-year 2025 financial results on Thursday, February 26, 2026, at 7:00 a.m. U.S. EST. Following the release of the financial results, Joe Ciaffoni, Chief Executive Officer, and other members of Indivior’s leadership team will host a presentation via live webcast at 8:00 a.m. U.S. EST.
Access to the Live Webcast Presentation:
The webcast event and materials can be accessed on the “Investors” section of the company’s website at www.indivior.com before the event begins.
Live webcast link: https://edge.media-server.com/mmc/p/f78ufsat
Participants may access the presentation telephonically by registering with the following link:
https://register-conf.media-server.com/register/BI44fe43e28e334eb58b41edf49f6f80ce
(Registrants will have an option to be called back directly immediately prior to the call or be provided a call-in # with a unique pin code following their registration)
A replay of the presentation will be available at www.indivior.com.
About Indivior
As the leader in long-acting injectable treatments for opioid use disorder (OUD), Indivior is singularly focused on delivering evidence-based treatment and advancing understanding of OUD as a chronic but treatable brain disease. For more than 25 years, we have revolutionized the science of addiction medicine — developing treatments that help people move toward long-term recovery with independence and dignity. Building on this heritage, we are ushering in a new era, renewing our commitment to individuals living with OUD and carrying forward what matters most: compassion, integrity, and science. Together – with science, people living with OUD, public health champions, and communities, we are powering recovery and renewing hope. Visit https://www.indivior.com/ to learn more. Connect with Indivior on LinkedIn by visiting https://www.linkedin.com/company/indivior.
For Further Information
Investors:
Jason Thompson
Indivior PLC
Tel: 804-402-7123
E-mail: jason.thompson@indivior.com
Media:
Cassie France-Kelly
Indivior PLC
Tel: 804-594-0836
E-Mail: Indiviormediacontacts@indivior.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.